Injection into the jugular vein among people who inject drugs in the United Kingdom: Prevalence, associated factors and harms.

[1]  J. Parry,et al.  Not in the vein: 'missed hits', subcutaneous and intramuscular injections and associated harms among people who inject psychoactive drugs in Bristol, United Kingdom. , 2016, The International journal on drug policy.

[2]  S. Strathdee,et al.  Prevalence and correlates of neck injection among people who inject drugs in Tijuana, Mexico. , 2015, Drug and alcohol review.

[3]  D. Ciccarone,et al.  Fire in the vein: Heroin acidity and its proximal effect on users' health. , 2015, The International journal on drug policy.

[4]  J. Parry,et al.  Going into the groin: Injection into the femoral vein among people who inject drugs in three urban areas of England. , 2015, Drug and alcohol dependence.

[5]  K. Page,et al.  HIV, HCV, and Health-Related Harms Among Women Who Inject Drugs: Implications for Prevention and Treatment , 2015, Journal of acquired immune deficiency syndromes.

[6]  J. Parry,et al.  Two decades of successes and failures in controlling the transmission of HIV through injecting drug use in England and Wales, 1990 to 2011. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[7]  E. Wood,et al.  Groin injecting among a community-recruited sample of people who inject drugs in Thailand , 2014, Substance Abuse Treatment, Prevention, and Policy.

[8]  Khodabakhsh Ahmadi,et al.  Drug Injection to Sites other than Arm: A Study of Iranian Heroin Injectors , 2013, Front. Psychiatry.

[9]  T. Rhodes,et al.  Venous access and care: harnessing pragmatics in harm reduction for people who inject drugs. , 2012, Addiction.

[10]  M. Golden,et al.  Prevalence and Characteristics of Femoral Injection among Seattle-Area Injection Drug Users , 2012, Journal of Urban Health.

[11]  R. Remien,et al.  Couple-Based HIV Prevention in the United States: Advantages, Gaps, and Future Directions , 2010, Journal of acquired immune deficiency syndromes.

[12]  N. Low,et al.  Mapping HIV/STI behavioural surveillance in Europe , 2010, BMC infectious diseases.

[13]  D. Ciccarone.  Heroin in brown, black and white: structural factors and medical consequences in the US heroin market. , 2009, The International journal on drug policy.

[14]  N. Hunt,et al.  Distributing foil from needle and syringe programmes (NSPs) to promote transitions from heroin injecting to chasing: An evaluation , 2008, Harm reduction journal.

[15]  J. Montaner,et al.  Prevalence and correlates of jugular injections among injection drug users. , 2008, Drug and alcohol review.

[16]  J. Strang,et al.  The Fine Line between Harm Reduction and Harm Production – Development of a Clinical Policy on Femoral (Groin) Injecting , 2008, European Addiction Research.

[17]  L. Topp,et al.  Prevalence and predictors of injecting‐related injury and disease among clients of Australia's needle and syringe programs , 2008, Australian and New Zealand journal of public health.

[18]  T. Rhodes,et al.  Crack-heroin speedball injection and its implications for vein care: qualitative study. , 2007, Addiction.

[19]  V. Hope,et al.  Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004 , 2007, Journal of viral hepatitis.

[20]  M. Hickman,et al.  Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales? , 2007, Journal of viral hepatitis.

[21]  T. Rhodes,et al.  Groin injecting in the context of crack cocaine and homelessness: From ‘risk boundary’ to ‘acceptable risk’? , 2006 .

[22]  J. Parry,et al.  HIV prevalence among injecting drug users in England and Wales 1990 to 2003: evidence for increased transmission in recent years , 2005, AIDS.

[23]  Jenny Scott,et al.  Use of the femoral vein ('groin injecting') by a sample of needle exchange clients in Bristol, UK , 2005, Harm reduction journal.

[24]  J. Parry,et al.  Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots , 2003, Journal of medical virology.

[25]  S. Darke,et al.  Physical injecting sites among injecting drug users in Sydney, Australia. , 2001, Drug and alcohol dependence.

[26]  J. Parry,et al.  Novel assay for the detection of immunoglobulin G antihuman immunodeficiency virus in untreated saliva and urine , 1993, Journal of medical virology.

[27]  D. Vlahov,et al.  Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. , 1993, Addiction.

[28]  E. Myers,et al.  The head and neck sequelae of cervical intravenous drug abuse , 1988, The Laryngoscope.

[29]  J. P. Elliott,et al.  Complications of attempted central venous injections performed by drug abusers. , 1980, Chest.

[30]  A. Pharris,et al.  Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. , 2014, The International journal on drug policy.